Ribonova Inc

Website
100 E Lancaster Ave
Wynnewood, PA 19096
https://www.ribonova.com

Ribonova Inc, located in Wynnewood, PA, is dedicated to helping patients suffering from serious rare diseases by discovering and developing novel medicines to treat their conditions. The company focuses on addressing the significant burden of mitochondrial disease, which affects approximately 75,000 people in the United States.

Ribonova's lead product candidate, R007, is a Phase 2 ready small molecule designed for the treatment of inherited mitochondrial disease. Through their innovative research and development efforts, Ribonova aims to make a meaningful impact on the lives of those affected by this devastating condition.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Ocms Bio, LLC

OCMS Bio, LLC is an innovative antibody discovery and engineering company based in Wynnewood, PA, dedicated to improving global health outcomes through the rapid development and optimization of antibody therapies. Utilizing AI-driven drug discovery alongside function-first antibody selection, OCMS aims to deliver safer, more efficacious, and convenient medicines for patients. The company addresses the challenges faced in the antibody industry by efficiently analyzing potential candidates to avoid the limitations commonly found in existing drugs. By rapidly discovering novel and optimized antibodies with a focus on binding, immunogenicity, stability, and function, OCMS is positioned to revolutionize the field of antibody therapies. Generated from the website

Treovir, LLC

Protein Architects Corp

Protein Architects Corp is a biotechnology company based in Narberth, PA, specializing in innovative protein engineering solutions. With a focus on designing and optimizing proteins for various applications, the company offers cutting-edge technology and expertise in the field of molecular biology. Generated from their business information
United States›Pennsylvania›Wynnewood›Ribonova Inc

Partial Data by Infogroup (c) 2025. All rights reserved.